Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Biosimilars and Pharmacovigilance: 5 Key Challenges

Posted on April 7th, 2016 by in Pharmacovigilance

The first biosimilar (Zarxio [filgrastim-sndz]) was approved in the US in March 2015, launching what some refer to as a “milestone in the maturity of medical biotechnology.”1 Continue reading “Biosimilars and Pharmacovigilance: 5 Key Challenges” »